💉 Zak Aria 💉

🩺 Zak-Aria (Pembrolizumab) 100 mg/4 ml (25 mg/ml): Immunotherapy drug (anti-PD-1 monoclonal antibody) for treating advanced cancers like melanoma, non-small cell lung cancer, head and neck cancer, Hodgkin lymphoma, stomach cancer, and metastatic tumors with specific genetic defects (like microsatellite instability). By blocking PD-1, it activates the immune system to attack cancer cells.
Application: Treatment of metastatic cancers and improving patient survival. Intravenous injection every 3-6 weeks, under physician supervision.
Manufacturer: CinnaGen, Iran.
Each box contains 1 injectable vial.